FindTrial
Sign In

Comparison of effect on pain relief between Programmed Intermittent Bolus and Continuous Infusion of drugs in ultrasound guided nerve block in upper limb surgery.

Analgesic efficacy of Programmed Intermittent Bolus vs. Continuous Infusion of ropivacaine and fentanyl in ultrasound guided infraclavicular brachial plexus block for upper limb surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023830
Enrollment
40
Registered
2020-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M849- Disorder of continuity of bone, unspecified

Interventions

Intervention1: Analgesic efficacy of programmed intermittent bolus of Ropivacaine and Fentanyl in Ultrasound Guided Infraclavicular Brachial Plexus Block for upper limb surgery: Patients will receive

Sponsors

Government Medical College and Hospital Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I-II, Age 18-65 years, BMI – 18-30 kg/m2,Either of the genders, Undergoing upper limb surgery distal to mid-humerus.

Exclusion criteria

Exclusion criteria: 1. Patient refusing to give informed consent 2. History of relevant drug allergy 3. History of psychiatric illness, substance abuse 4. Severe cardiovascular, respiratory, metabolic or neurological disease 5. Pregnancy and lactation 6. Coagulopathy 7. Contralateral phrenic nerve dysfunction 8. Infection at planned injection site 9. Patients on steroids

Design outcomes

Primary

MeasureTime frame
Total 48-h consumption of local anaesthetic-opioid mixture (in ml) by patient controlled regional analgesiaTimepoint: 48 hours—

Secondary

MeasureTime frame
1. Pain assessment using 11-point (0-10) numerical rating scale (NRS) over 48h study period at time intervals of 1, 4, 12, 24, 36 and 48h 2. Sensory and motor blockade 3. Patient satisfaction 4. Adverse effectsTimepoint: 48 hours—

Countries

India

Contacts

Public ContactProf Sukanya Mitra

Government Medical College and Hospital, Chandigarh

drsmitra12@yahoo.com9646121521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026